共 51 条
[1]
Lischka A(2020)Genome instability profiles predict disease outcome in a cohort of 4,003 patients with breast cancer Clin Cancer Res 26 4606-4615
[2]
Doberstein N(2005)Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance J Natl Cancer Inst 97 1254-1261
[3]
Freitag-Wolf S(2009)Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat Med 15 907-913
[4]
Kocak A(2014)Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics Cancer Epidemiol Biomarkers Prev 23 714-724
[5]
Gemoll T(2014)Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes Cancer Epidemiol Biomarkers Prev 23 725-734
[6]
Heselmeyer-Haddad K(2015)Progesterone exposure and breast cancer risk: understanding the biological roots JAMA Oncol 1 283-285
[7]
Arpino G(2010)Progesterone induces adult mammary stem cell expansion Nature 465 803-807
[8]
Weiss H(2015)Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 women's health initiative randomized clinical trials JAMA Oncol 1 296-305
[9]
Lee AV(2012)Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Cancer Epidemiol Biomark Prevent 21 134-147
[10]
Schiff R(undefined)undefined undefined undefined undefined-undefined